Research Article

Identification of Chemical Components of Qi-Fu-Yin and Its Prototype Components and Metabolites in Rat Plasma and Cerebrospinal Fluid via UPLC-Q-TOF-MS

Table 2

Characterization of prototypical components and metabolites in rat plasma and cerebrospinal fluid after oral administration of Qi-Fu-Yin.

No.tR (min)NameFormulaTheoretical mass (Da)Measured mass (Da)Error (ppm)Precursor ionsMain MS/MS fragment ionsPCSF

P14.17Sibiricose A5C22H30O14517.1563517.15660.6[M − H]193.0514, 175.0405, 160.0170+
P25.13Sibiricose A1C23H32O15547.1668547.1658−1.8[M − H]367.1030, 223.0627, 205.0508, 190.0274+
P37.31MagnoflorineC20H23NO4+342.1700342.1697−0.8[M + H]+297.1119, 282.0888, 265.0843+
P413.59LiquiritinC21H22O9417.1191417.1189−0.5[M − H]255.0666, 135.0091, 119.0508+
P514.07Polygalaxanthone IIIC25H28O15567.1355567.1352−0.5[M − H]435.0944, 357.0600, 345.0606, 315.0522, 297.0395+
P614.16Liquiritin apiosideC26H30O13549.1614549.1609−0.9[M − H]255.0662, 417.1186, 175.02373, 135.0086, 113.0248+
P714.85SpinosinC28H32O15607.1668607.1665−0.5[M − H]487.1252, 445.1177, 367.0823, 337.0722, 307.0614+
P817.24Senkyunolide IC12H16O4207.1015207.1012−1.4[M + H–H2O]+189.0910, 161.1026, 147.0814++
P918.77Senkyunolide HC12H16O4207.1015207.1013−1.0[M + H–H2O]+++
P1018.883,6′-Disinapoyl sucroseC34H42O19753.2248753.22510.4[M − H]547.1668, 529.1565, 265.0748, 223.0595, 205.0540++
P1119.463,4,5-Trimethoxycinnamic acidC12H14O5237.0768237.0766−0.8[M − H]193.0870, 161.0609, 108.0217+
P1220.90Isoliquiritin apiosideC26H30O13549.1614549.16282.5[M − H]255.0664, 135.0077, 119.0515+
P1321.29IsoliquiritinC21H22O9417.1191417.11951.0[M − H]255.0659, 135.0089, 119.0499+
P1421.58Tenuifoliside AC31H38O17681.2036681.2002−5.0[M − H]179.0327, 137.0244+
P1522.35LiquiritigeninC15H12O4255.0663255.06650.8[M − H]135.0087, 119.0503+
P1623.69Senkyunolide D or isomerC12H14O4221.0819221.08231.8[M − H]177.0927, 147.0459+
P1724.48Ginsenoside Rg1C42H72O14845.4904845.4900−0.5[M + COOH]475.3815, 179.0564, 161.0454+
P1824.85Ginsenoside ReC48H82O18991.5483991.5436−4.7[M + COOH]783.4934, 475.3719, 179.0566, 161.0460+
P1926.01Senkyunolide D or isomerC12H14O4221.0819221.08210.9[M − H]177.0925, 147.0453, 134.0374+
P2030.70Aeginetic acidC15H24O4267.1602267.16082.2[M − H]178.9213, 153.0928+
P2132.08Polygalasaponin XXVIIIC53H84O241103.52801103.52800.0[M − H]455.3189, 425.3078+
P2232.66Senkyunolide F or isomerC12H14O3205.0870205.08721.0[M − H]161.0977, 187.9911, 149.0043+
P2332.90ButylidenephthalideC12H12O2189.0910189.09131.6[M + H]+171.0768, 161.0935, 143.0845, 117.0676++
P2433.22ButylphthalideC12H14O2191.1066191.1064−1.0[M + H]+++
P2534.01Ginsenoside RfC42H72O14845.4904845.4887−2.0[M + COOH]179.0575, 161.0465+
P2634.38Senkyunolide A or isomerC12H16O2193.1223193.12282.6[M + H]+147.1167, 175.1169, 137.0591+
P2735.35Licorice saponin A3C48H72O21983.4493983.4463−3.1[M − H]351.0583, 193.0364+
P2835.64IsoliquiritigeninC15H12O4255.0663255.0658−2.0[M − H]135.0083, 119.0498+
P2935.83FormononetinC16H12O4267.0663267.0657−2.2[M − H]+
P3036.61TenuifolinC36H56O12679.3699679.37182.8[M − H]455.3136, 425.3101++
P3136.8022-Hydroxyl-glycyrrhizinC42H62O17837.3914837.3894−2.4[M − H]351.0584, 193.0366+
P3236.8920(S)-Ginsenoside Rh1C36H62O9683.4376683.4367−1.3[M + COOH]637.4335, 475.3806, 161.0462++
P3337.37Senkyunolide A or isomerC12H16O2193.1223193.12240.5[M + H]+175.1158, 147.1162, 137.0595+
P3437.6620(R)-Ginsenoside Rh1C36H62O9683.4376683.4367−1.3[M + COOH]161.0463++
P3537.85Jujuboside AC58H94O261251.60151251.5971−3.5[M + COOH]179.0566, 161.0465+
P3638.72Ginsenoside Rb1C54H92O231153.60111153.5980−2.7[M + COOH]1107.5959+
P3739.69Ginsenoside RoC48H76O19955.4908955.4899−0.9[M − H]793.4379, 179.0563, 119.0352+
P3839.69Ginsenoside RcC53H90O221123.59061123.5856−4.5[M + COOH]459.3809, 149.0451, 191.0563+
P3939.78Licorice saponin G2C42H62O17837.3914837.3891−2.7[M − H]351.056, 193.0351+
P4040.75Ginsenoside Rb2C53H90O221123.59061123.59080.2[M + COOH]1077.5866+
P4141.32RhaoglycyrrhizinC48H72O20967.4544967.4506−3.9[M − H]1077.5859+
P4242.76Glycyrrhizic acidC42H62O16821.3965821.3942−2.8[M − H]645.3641, 351.0564, 193.0351, 175.0249+
P4342.76Ginsenoside RdC48H82O18991.5483991.5474−0.9[M + COOH]179.0564, 161.0456+
P4444.63Atractylenolide IC15H18O2231.1379231.1378−0.4[M + H]++
P4546.13Licorice saponin J2C42H64O16823.4122823.4091−3.8[M − H]351.0573, 193.0357+
P4646.90Ginsenoside Rk3C36H60O8665.4270665.4248−3.3[M + COOH]161.0449+
P4747.09Ginsenoside Rh4C36H60O8665.4270665.4258−1.8[M + COOH]161.0450+
P4847.38Zingibroside R1C42H66O14793.4380793.4374−0.8[M − H]731.4388, 631.3849++
P4947.86Ginsenoside Rg3C42H72O13829.4955829.4934−2.5[M − H]783.4886, 621.4365, 459.3812, 161.0454+
P5049.40Z-LigustilideC12H14O2191.1066191.10702.1[M + H]++
P5152.30Glycyrrhetinic acidC30H46O4469.3323469.3316−1.5[M − H]425.3414++
M18.78Ferulic acid-4-sulfateC10H10O7S273.0074273.00740.0[M − H]193.0507, 149.0246+
M29.45Ferulic acid-4-sulfate isomerC10H10O7S273.0074273.0073−0.4[M − H]193.0504, 149.0245+
M313.59Liquiritigenin-7-O-glucuronideC21H20O10431.0984431.0977−1.6[M − H]255.0662, 175.0250, 135.0088++
M413.97Liquiritigenin-4′-O-glucuronideC21H20O10431.0984431.0982−0.5[M − H]255.0662, 175.025, 135.0088++
M515.70Liquiritigenin+2H + sulfateC15H14O7S337.0382337.0380−0.6[M − H]257.0824+
M617.83Liquiritigenin-4′-O-sulfateC15H12O7S335.0231335.0225−1.8[M − H]255.0664, 135.0088, 119.0503+
M719.36(Iso)Liquiritigenin+2H + sulfateC15H14O7S337.0382337.03830.3[M − H]257.0823, 151.0401+
M820.81(Iso)Liquiritigenin+2H + sulfateC15H14O7S337.0382337.03850.9[M − H]257.0820, 151.0398+
M921.10Formononetin-7-O-glucuronideC22H20O10443.0984443.09840.0[M − H]267.0661, 175.0249, 135.0453+
M1023.12Isoliquiritigenin-4′-O-glucuronideC21H20O10431.0984431.0978−1.4[M − H]255.0662, 175.0247, 135.0088++
M1127.07Isoliquiritigenin+2H + sulfateC15H14O7S337.0382337.03902.4[M − H]257.0821+
M1228.20Acetylcysteine conjugate of senkyunolide I or senkyunolide HC17H23NO6S370.1324370.1316−2.2[M + H]+207.1024, 189.0925, 161.0957+
M1329.38Formononetin-7-O-sulfateC16H12O7S347.0231347.0230−0.3[M − H]267.0664, 252.0429+
M1429.67Isoliquiritigenin-6′-O-sulfateC15H12O7S335.0231335.02361.5[M − H]255.0666, 135.009, 119.0508+
M1538.72Compound K-H2C36H60O8619.4215619.4193−3.6[M − H]457.3683, 439.3216+
M1645.27Compound KC36H62O8621.4372621.4355−2.7[M − H]459.3846, 179.0559, 161.0453+
M1745.94Compound K+2O-2H2C36H58O10665.3906665.3883−3.5[M − H]651.4118, 409.2751, 375.2533+
M1846.42Compound K+3O-H2C36H59O11667.4063667.4047−2.4[M − H]605.4042, 491.3720, 175.0237, 113.0242+
M1946.90Compound K+3O-H2C36H59O11667.4063667.4042−3.1[M − H]605.4029, 491.3724, 175.0241, 113.0242+
M2046.99Compound K+2O-2H2C36H58O10665.3906665.3893−2.0[M − H]651.4113, 409.2746, 375.2527+
M2147.76Compound K+2O-2H2C36H58O10665.3906665.3897−1.4[M − H]651.4119, 409.2752, 375.2535+
M2248.13Glycyrrhetinic acid-2HC30H44O4469.3318469.3312−1.3[M+H]+451.3203, 423.3243+
M2348.15Glycyrrhetinic acid + OC30H46O5485.3272485.3263−1.9[M − H]441.3357++
M2448.34Compound K+2O-2H2C36H58O10665.3906665.3904−0.3[M − H]491.3368, 473.3269, 443.3161, 193.0352, 175.0246, 113.0242+
M2548.92Glycyrrhetinic acid + OC30H46O5485.3272485.3256−3.3[M − H]441.3361++
M2649.59Protopanaxadiol+2O + H2C30H50O5489.3585489.3575−2.0[M − H]473.3261, 445.3677, 375.2896+
M2745.36Glycyrrhetinic acid + OC30H46O5485.3272485.32791.4[M − H]441.3383+

P, plasma; CSF, cerebrospinal fluid; −, not detected +, detected.